Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients?
Objective. The aim of this review is to clarify the usefulness of bone, cartilage, and synovial biomarker in the management of rheumatoid arthritis (RA) therapy in remission. Synovial Biomarkers. High MMP-3 levels are associated with joint progression in RA patients, but there is no data about their...
Saved in:
Main Authors: | Delphine Dénarié, Elodie Constant, Thierry Thomas, Hubert Marotte |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/537324 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Whole-Genome Expression Analysis and Signal Pathway Screening of Synovium-Derived Mesenchymal Stromal Cells in Rheumatoid Arthritis
by: Jingyi Hou, et al.
Published: (2016-01-01) -
The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland
by: Joanna Bartosińska, et al.
Published: (2015-01-01) -
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis
by: Manuela Di Franco, et al.
Published: (2018-01-01) -
Ultrasonography of articular and periarticular structures as a relapse predictor in patients with clinically remitted rheumatoid arthritis
by: Mehdi Karami, et al.
Published: (2020-01-01) -
Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair
by: Zongquan Zhang, et al.
Published: (2025-01-01)